# Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

> **NCT00321672** · PHASE3 · COMPLETED · sponsor: **NeurogesX** · enrollment: 494 (actual)

## Conditions studied

- Pain
- HIV Infections
- Peripheral Nervous System Diseases

## Interventions

- **DRUG:** NGX-4010, 8% capsaicin patch
- **DRUG:** 0.04% capsaicin patch
- **DRUG:** NGX-4010, 8% capsaicin patch
- **DRUG:** 0.04% capsaicin patch

## Key facts

- **NCT ID:** NCT00321672
- **Lead sponsor:** NeurogesX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2011-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321672, "Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00321672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*